Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Capital Leases: 2015-2019

Historic Capital Leases for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $3.4 million.

  • Outlook Therapeutics' Capital Leases fell 98.53% to $49,162 in Q2 2020 from the same period last year, while for Jun 2020 it was $49,162, marking a year-over-year decrease of 98.53%. This contributed to the annual value of $3.4 million for FY2019, which is 2.53% down from last year.
  • According to the latest figures from FY2019, Outlook Therapeutics' Capital Leases is $3.4 million, which was down 2.53% from $3.5 million recorded in FY2018.
  • In the past 5 years, Outlook Therapeutics' Capital Leases ranged from a high of $3.5 million in FY2018 and a low of $28,067 during FY2017.
  • For the 3-year period, Outlook Therapeutics' Capital Leases averaged around $2.3 million, with its median value being $3.4 million (2019).
  • In the last 5 years, Outlook Therapeutics' Capital Leases plummeted by 91.25% in 2017 and then skyrocketed by 12,203.62% in 2018.
  • Over the past 5 years, Outlook Therapeutics' Capital Leases (Yearly) stood at $1.2 million in 2015, then plummeted by 73.70% to $320,737 in 2016, then tumbled by 91.25% to $28,067 in 2017, then surged by 12,203.62% to $3.5 million in 2018, then decreased by 2.53% to $3.4 million in 2019.